Report Highlights
The cure for a disease depends mostly on individual and hereditary biology, the markers across generations and behavior patterns. The more knowledge acquired, the greater the chances of finding better treatments for various diseases and their variants.
This blast from the past is biology’s next serious leap.
With more than 5 million users and a market value exceeding $2 billion, 23andMe boasts partners such as GlaxoSmithKline and Warren Buffett.
Report Includes
- An introduction to the concept of citizen bioscience and a brief discussion of the citizen science ecosystem that has gained momentum in the developing world during the last decade
- Showcase of current projects from around the world and assessment of the potential of multiple sub-sectors to answer the question: Is Citizen Bioscience the Next Frontier?
- Information on some active citizen bioscience projects and initiatives which have been remarkably successful in advancing scientific knowledge, and contributions from citizen scientists around the world
- Discussion of an initiative called Citizen Data Science, and growth prospects for citizen data scientists in the healthcare industry
Analyst Credentials
The analyst of this report, Smruti Munshi, has specialized in the medical technologies space for more than five years. She focuses on monitoring and analyzing emerging trends, technologies, competitive benchmarking, and market dynamics in the medical imaging industry. She has worked on several projects spanning the EMEA markets, ranging from market insights, industry overviews, to comprehensive marketing and technology-oriented custom consulting. Ms. Munshi has an MS in Biomedical Engineering and a BS in Instrumentation and Control Engineering. She has authored several reports for BCC Research in the medical field.
Related Reports
Biohacking
Biohacking, simply put, is do-it-yourself (DIY) biology; it gives everyone — individuals, communities, small group organizations, not just research institutions — the ability to deconstruct and reconstruct biology using simple kits or supplements for the purpose of not only achieving their immediate outcomes, but also contributing to solving larger issues. As an emerging industry and social movement, biohacking represents a new frontier in the development of drugs and therapeutics, and consequently, is a market expected to see exceptionally high growth over the next five years. This BCC Research special report offers an overview of biohacking, and how this growing industry can spur the interest of prospective investors, large corporations and everyday hackers who could be inspired uncover the next big medical breakthrough.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More